The US FDA is permitting the restricted use of Zelnorm [tegaserod] under a treatment investigational new drug protocol Media release 18 January 2013 Pages: 2 - 2
The US FDA has placed a clinical hold on an investigational gene therapy product for the treatment of active inflammatory arthritis Media release 18 January 2013 Pages: 2 - 2
Cases of active tuberculosis (TB) in tumour necrosis factor (TNF) antagonist recipients continue to occur due to noncompliance with recommendations Clinical study 18 January 2013 Pages: 4 - 4
Inhospital use of opioids increases the occurrence of postoperative paralytic ileus Clinical study 18 January 2013 Pages: 4 - 4